TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Biosite AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
145,805
|
122,360
|
119,100 |
Financial expenses |
109
|
3,153
|
6,828 |
Earnings before taxes |
22,318
|
10,122
|
13,799 |
EBITDA |
20,610
|
11,584
|
18,376 |
Total assets |
52,271
|
43,128
|
55,544 |
Current assets |
50,319
|
39,242
|
47,877 |
Current liabilities |
22,310
|
16,303
|
15,185 |
Equity capital |
25,348
|
22,100
|
35,000 |
- share capital |
102
|
96
|
98 |
Employees (average) |
16
|
20
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
48.5%
|
51.2%
|
63.0% |
Turnover per employee |
9,113
|
6,118
|
6,268 |
Profit as a percentage of turnover |
15.3%
|
8.3%
|
11.6% |
Return on assets (ROA) |
42.9%
|
30.8%
|
37.1% |
Current ratio |
225.5%
|
240.7%
|
315.3% |
Return on equity (ROE) |
88.0%
|
45.8%
|
39.4% |
Change turnover |
14,762
|
6,840
|
-97,692 |
Change turnover % |
11%
|
6% | |
Chg. No. of employees |
-4
|
1
|
-13 |
Chg. No. of employees % |
-20%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.